All News

RheumNow Podcast square

3-4-5 Rule (5.26.2023)

Jack Cush, MD

Dr. Jack Cush reviews more than a dozen news, journal articles and RNL highlights from this past week on RheumNow.com.

Read Article
Rheumatoid,RA,nodules,damage

Prevalence of Psoriatic Arthritis, Spondyloarthritis and Rheumatoid Arthritis in Norway

Jack Cush, MD

Recent reports have suggested a rising and unrecognized number of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) compared to rheumatoid arthritis (RA).

Read Article
NSAIDs.pills_.caps_.jpg

NSAID Prescribing Decreasing

Jack Cush, MD

Multinational metanalyses of data between 1989 and 2022 shows that NSAID prescriptions have decreased over time, and differs according to geographical locations.

Read Article
SI AS SpA ACR

ICYMI: Spondyloarthritis Innovations

Robert Chao, MD

The second day of RheumNow Live 2023 held in March ended with a focus on axial spondyloarthritis, especially on the evaluation of the definition of the disease, the inheritance of it, and of course the treatment of it.

Read Article
PSA068.jpg

Disappointing Secondary Use of Newer Therapies in Psoriatic Arthritis

Jack Cush, MD

Analysis of patient data from five Nordic registries shows that the uptake of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in psoriatic arthritis (PsA) was mainly in biologic-experienced patients.

Read Article
Giants,women,rheumatology

25 Great Women in Rheumatology

Jack Cush, MD

This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? This was prompted by a smart article in Annals of Rheumatic Disease written by Drs. Tuhina Neogi (Boston) and Nicola Dalbeth (N. Zealand), entitled "Where are the women ‘Heroes and Pillars of Rheumatology’?

Read Article
RheumNow Podcast square

“You Can Have it All” (4.7.2023)

Jack Cush, MD

Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow.com

Read Article
Dennis Poddubnyy #RNL2023 MRI sequences for axSpA: Semi-coronal- T1 weighted, T2 STIR, T1 weighted w fat suppression Semi-axial- T2 STIR @RheumNow https://t.co/aidLu7GcQH https://t.co/YOrboYl6pW

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Deodhar reminds us of his "3,4,5 rule" for diagnosing AS. *Erosions in 3 or more SIJ quadrants *BME in 4 or more SIJ quadrants *Fat lesions in 5 of more SIJ quadrants #RNL2023 @RheumNow https://t.co/T9iWLcNL8b https://t.co/BskCNz9Klj

Links:

Dr. John Cush RheumNow ( View Tweet)
AxSpA is primarily a genetic disease - clusters in families, especially HLA-B27+ first degree relatives - genetic testing for asymptomatic relatives not recommended @RheumNow #RNL2023 https://t.co/WeNApLE5to https://t.co/zDzHfdmpCG

Links:

Dr. John Cush RheumNow ( View Tweet)
Risk of familial AS is 19.4%, Reveille #RNL2023 ⁦@RheumNow⁩ https://t.co/7CzaXgqkPG https://t.co/KrmKGblVmd

Links:

Dr. John Cush RheumNow ( View Tweet)
"50 years ago in April we discovered HLA B27." Dr. Reveille #RNL2023 @RheumNow

Dr. John Cush RheumNow ( View Tweet)

Bimekizumab is a dual IL-17A and IL-17F inhibitor, for nr-axSpA and AS - it works but is it different from existing IL-17i? - appears to work well in TNFi-inadequate responders - are TNFi-IR pts immunologically different? #RNL2023 https://t.co/bHboX3Xz6M https://t.co/kCa9MbFdxs

Links:

Dr. John Cush RheumNow ( View Tweet)
Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/0mC7PxF0DU https://t.co/klbnwjcPbM

Links:

Dr. John Cush RheumNow ( View Tweet)
TNR: Private Practice & Academia In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/yMJ5mCtSXX @KDAO2011 https://t.co/eeFYkLYsAh

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Philip Mease speaks about the effect of sex and gender on rheumatology disease activity and treatment response. Learn more. https://t.co/vKZfFLFmgs https://t.co/kRA0w9hRX7

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us April 18 for: Private Practice & Academia In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/BrWG57mRRG https://t.co/A0pzEvJ3cu

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particular focus on medication use. Watch now. https://t.co/Ine8CdbZR4 https://t.co/7UnanlnQcC

Links:

Dr. John Cush RheumNow ( View Tweet)
Dutch Biologic Monitor surveys of RA, PsA, axSpA pts on etanercept or adalimumab, looked at adverse drug reactions. Among 748 consecutive pts on biologics, women had more ADRs (55%) than men (38%). nature ofreported ADRs differed betw sexes (p = 0.02). https://t.co/fGRgX4IJLR https://t.co/FJE7BrKPfQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Analysis of 886 SpA pts in the Ankylosing Spondylitis Registry of Ireland shows women have worse BASDAI (4.57 vs 3.83, p < 0.01) & ASQoL (7.51 vs 6.12, p < 0.01) scores than males. higher scores in females due to all 6 BASDAI components https://t.co/2kt6t9MXUB https://t.co/o056cgF43V

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×